Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Theodore Karrison   and   Michael Bishop.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.201
         
        
        
     
 
    
        
        - 
            FLT3 inhibitor maintenance after allogeneic stem cell transplantation in FLT3-mutated acute myeloid leukemia (AML) patients. Ann Transl Med. 2024 Jun 10; 12(3):49.
            
            
                Score: 0.056
            
         
        
        - 
            Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions. Blood Adv. 2023 08 22; 7(16):4528-4538.
            
            
                Score: 0.054
            
         
        
        - 
            Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2023 03 28; 7(6):963-970.
            
            
                Score: 0.052
            
         
        
        - 
            Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
            
            
                Score: 0.039